BioInvent and Transgene and report positive BT-001 data
25th May 2023 Uncategorised 0Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns
More: BioInvent and Transgene and report positive BT-001 data
Source: News
Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns
More: BioInvent and Transgene and report positive BT-001 data
Source: News
© 1994 - 2026 B.M. Pharmaceuticals